Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID Reference, 5th edition, 486 pages

Free download


  Prostate Cancer

  Free Subscription


30.11.2020

1 BMC Cancer
1 Br J Cancer
1 Cancer
1 Clin Imaging
1 Eur J Radiol
1 Eur Radiol
1 Eur Urol
1 Int J Radiat Oncol Biol Phys
2 Int J Urol
2 J Magn Reson Imaging
1 J Nucl Med
4 J Urol
6 Oncogene
1 Semin Radiat Oncol
1 Urology


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    BMC Cancer

  1. SIMMONS AD, Nguyen M, Pintus E
    Polyclonal BRCA2 mutations following carboplatin treatment confer resistance to the PARP inhibitor rucaparib in a patient with mCRPC: a case report.
    BMC Cancer. 2020;20:215.
    PubMed         Abstract available


    Br J Cancer

  2. ZHAO Z, Zhao S, Luo L, Xiang Q, et al
    miR-199b-5p-DDR1-ERK signalling axis suppresses prostate cancer metastasis via inhibiting epithelial-mesenchymal transition.
    Br J Cancer. 2020 Nov 26. pii: 10.1038/s41416-020-01187.
    PubMed         Abstract available


    Cancer

  3. SOHLBERG EM, Thomas IC, Yang J, Kapphahn K, et al
    Laboratory-wide association study of survival with prostate cancer.
    Cancer. 2020 Nov 25. doi: 10.1002/cncr.33341.
    PubMed         Abstract available


    Clin Imaging

  4. PATEL N, Foster BR, Korngold EK, Jensen K, et al
    MRI of prostatic urethral mucinous urothelial carcinoma: Expanding the differential diagnosis for T2 hyperintense prostatic masses.
    Clin Imaging. 2020;68:68-70.
    PubMed         Abstract available


    Eur J Radiol

  5. CHRISTOPHE C, Montagne S, Bourrelier S, Roupret M, et al
    Erratum to 'Prostate cancer local staging using biparametric MRI: Assessment and comparison with multiparametric MRI' [Eur. J. Radiol. 132 (2020) 109350].
    Eur J Radiol. 2020 Nov 20:109417. doi: 10.1016/j.ejrad.2020.109417.
    PubMed        


    Eur Radiol

  6. PADHANI AR, Schoots IG, Turkbey B, Giannarini G, et al
    A multifaceted approach to quality in the MRI-directed biopsy pathway for prostate cancer diagnosis.
    Eur Radiol. 2020 Nov 25. pii: 10.1007/s00330-020-07527.
    PubMed         Abstract available


    Eur Urol

  7. HUEBNER NA, Shariat SF
    Clinical Impact and Statistical Significance of Multiparametric Magnetic Resonance Imaging for Local Staging of Prostate Cancer.
    Eur Urol. 2020 Nov 24. pii: S0302-2838(20)30860.
    PubMed        


    Int J Radiat Oncol Biol Phys

  8. WAGES NA, Sanders JC, Smith A, Wood S, et al
    Hypofractionated post-prostatectomy radiotherapy for prostate cancer to reduce toxicity and improve patient convenience: A Phase I/II trial.
    Int J Radiat Oncol Biol Phys. 2020 Nov 20. pii: S0360-3016(20)34497.
    PubMed         Abstract available


    Int J Urol

  9. KATO M, Sasaki T, Inoue T
    Current experimental human tissue-derived models for prostate cancer research.
    Int J Urol. 2020 Nov 27. doi: 10.1111/iju.14441.
    PubMed         Abstract available

  10. SHIRAISHI K
    Editorial Comment to Three-dimensional analysis of systematic biopsy-derived prostate cancer upgrading over targeted biopsy: Potential of target margin and surrounding region sampling using magnetic resonance-ultrasound image fusion systems.
    Int J Urol. 2020 Nov 24. doi: 10.1111/iju.14446.
    PubMed        


    J Magn Reson Imaging

  11. TONG A, Lemberskiy G, Huang C, Shanbhogue K, et al
    Exploratory study of geometric distortion correction of prostate diffusion-weighted imaging using B0 map acquisition.
    J Magn Reson Imaging. 2019 Apr 16. doi: 10.1002/jmri.26751.
    PubMed         Abstract available

  12. ZANELLI E, Giannarini G, Cereser L, Zuiani C, et al
    Head-to-head comparison between multiparametric MRI, the partin tables, memorial sloan kettering cancer center nomogram, and CAPRA score in predicting extraprostatic cancer in patients undergoing radical prostatectomy.
    J Magn Reson Imaging. 2019 Apr 7. doi: 10.1002/jmri.26743.
    PubMed         Abstract available


    J Nucl Med

  13. RAY S, Lisok A, Minn IL, Josefsson A, et al
    Preclinical evaluation of (213)Bi-/(225)Ac-labeled low-molecular-weight compounds for radiopharmaceutical therapy of prostate cancer.
    J Nucl Med. 2020 Nov 27. pii: jnumed.120.256388. doi: 10.2967/jnumed.120.256388.
    PubMed         Abstract available


    J Urol

  14. DEWITT-FOY ME, Gam K, Modlin C, Kim SP, et al
    Race, Decisional Regret and Prostate Cancer Beliefs: Identifying Targets to Reduce Racial Disparities in Prostate Cancer.
    J Urol. 2020 Nov 23:101097JU0000000000001385. doi: 10.1097/JU.0000000000001385.
    PubMed         Abstract available

  15. GINSBURG KB, Cher ML, Montie JE
    Defining Quality Metrics for Active Surveillance: The Michigan Urological Surgery Improvement Collaborative Experience.
    J Urol. 2020;204:1119-1121.
    PubMed        

  16. MARRA G, Zhuang J, Marquis A, Zhao X, et al
    Pain in Men Undergoing Transperineal Free-Hand Multiparametric Magnetic Resonance Imaging Fusion Targeted Biopsies under Local Anesthesia: Outcomes and Predictors from a Multicenter Study of 1,008 Patients.
    J Urol. 2020;204:1209-1215.
    PubMed         Abstract available

  17. CONNOR MJ, Eldred-Evans D, van Son M, Hosking-Jervis F, et al
    A Multicenter Study of the Clinical Utility of Nontargeted Systematic Transperineal Prostate Biopsies in Patients Undergoing Pre-Biopsy Multiparametric Magnetic Resonance Imaging.
    J Urol. 2020;204:1195-1201.
    PubMed         Abstract available


    Oncogene

  18. YADAV S, Anbalagan M, Baddoo M, Chellamuthu VK, et al
    Somatic mutations in the DNA repairome in prostate cancers in African Americans and Caucasians.
    Oncogene. 2020;39:4299-4311.
    PubMed         Abstract available

  19. HE Y, Mi J, Olson A, Aldahl J, et al
    Androgen receptor with short polyglutamine tract preferably enhances Wnt/beta-catenin-mediated prostatic tumorigenesis.
    Oncogene. 2020;39:3276-3291.
    PubMed         Abstract available

  20. ALI S, Zhang Y, Zhou M, Li H, et al
    Functional deficiency of DNA repair gene EXO5 results in androgen-induced genomic instability and prostate tumorigenesis.
    Oncogene. 2020;39:1246-1259.
    PubMed         Abstract available

  21. CHEN X, Xiong X, Cui D, Yang F, et al
    DEPTOR is an in vivo tumor suppressor that inhibits prostate tumorigenesis via the inactivation of mTORC1/2 signals.
    Oncogene. 2020;39:1557-1571.
    PubMed         Abstract available

  22. LOVERIDGE CJ, Slater S, Campbell KJ, Nam NA, et al
    BRF1 accelerates prostate tumourigenesis and perturbs immune infiltration.
    Oncogene. 2020;39:1797-1806.
    PubMed         Abstract available

  23. LI J, Pu T, Yin L, Li Q, et al
    MAOA-mediated reprogramming of stromal fibroblasts promotes prostate tumorigenesis and cancer stemness.
    Oncogene. 2020;39:3305-3321.
    PubMed         Abstract available


    Semin Radiat Oncol

  24. O'DWYER E, Bodei L, Morris MJ
    The Role of Theranostics in Prostate Cancer.
    Semin Radiat Oncol. 2021;31:71-82.
    PubMed         Abstract available


    Urology

  25. SCHMANKE K, Okut H, Ablah E
    Trends for Stage and Grade Group of Prostate Cancer in the US (2010-2016).
    Urology. 2020 Nov 20. pii: S0090-4295(20)31399.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Prostate Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: